Mathilda Mandel
Ramat Gan, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Deciphering the shift from benign to active relapsing-remitting multiple sclerosis: Insights into T regulatory cell dysfunction and apoptosis regulation.
Journal: Neurobiology of disease
Published: January 07, 2024
In-depth characterization of long-term humoral and cellular immune responses to COVID-19m-RNA vaccination in multiple sclerosis patients treated with teriflunomide or alemtuzumab.
Journal: Multiple sclerosis and related disorders
Published: February 04, 2023
Intravenous immunoglobulin treatment during pregnancy and the post-partum period in women with multiple sclerosis: A prospective analysis.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: October 10, 2022
Cladribine treatment for highly active multiple sclerosis: Real-world clinical outcomes for years 3 and 4.
Journal: Journal of neuroimmunology
Published: June 18, 2022
COVID-19 Alpha Variant (B.1.1.7): Humoral, memory B and T cells in COVID-19 pediatric convalescents.
COVID-19 Alpha Variant (B.1.1.7): Humoral, memory B and T cells in COVID-19 pediatric convalescents.
Journal: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology
Published: May 30, 2022
The intercorrelations between blood levels of ferritin, sCD163, and IL-18 in COVID-19 patients and their association to prognosis.
Journal: Immunologic research
Published: March 06, 2022
Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod.
Journal: Journal of neurology
Published: December 15, 2021
COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose.
Journal: Journal of the neurological sciences
Published: November 08, 2021
Humoral SARS-COV-2 IgG decay within 6 months in COVID-19 healthy vaccinees: The need for a booster vaccine dose?
Journal: European journal of internal medicine
Published: October 11, 2021
SARS-CoV-2 memory B and T cell profiles in mild COVID-19 convalescent patients.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: October 01, 2021
Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study.
Journal: Journal of neuroimmunology
Published: August 31, 2021
Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies.
Journal: Therapeutic advances in neurological disorders
Published: June 09, 2021
Last Updated: 09/26/2026